Caseware UK (AP4) 2024.0.164 2024.0.164 2024-11-302024-11-301false2023-12-01falseNo description of principal activity1trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 08777520 2023-12-01 2024-11-30 08777520 2022-12-01 2023-11-30 08777520 2024-11-30 08777520 2023-11-30 08777520 c:Director1 2023-12-01 2024-11-30 08777520 d:CurrentFinancialInstruments 2024-11-30 08777520 d:CurrentFinancialInstruments 2023-11-30 08777520 c:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 08777520 c:FullAccounts 2023-12-01 2024-11-30 08777520 c:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 08777520 c:Micro-entities 2023-12-01 2024-11-30 08777520 e:PoundSterling 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Registered number: 08777520









SUSHEN HAEMATOLOGY LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2024

 
SUSHEN HAEMATOLOGY LTD
REGISTERED NUMBER: 08777520

BALANCE SHEET
AS AT 30 NOVEMBER 2024

2024
2023
£
£


Fixed assets
52,267
54,270

Current assets
88,373
65,001

Creditors: amounts falling due within one year
(12,855)
(9,472)

Net current assets
 
 
75,518
 
 
55,529

Total assets less current liabilities
127,785
109,799


Net assets
127,785
109,799



Capital and reserves
127,785
109,799


Notes


General information

Sushen Haematology Ltd is a private company limited by shares and is incorporated and domiciled in England and Wales, registration number 08777520. The registered office is 56A Haverstock Hill, London NW3 2BH.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


................................................
RAJEEV GUPTA
Director

Date: 18 August 2025

Page 1

 
SUSHEN HAEMATOLOGY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 105 the UK and the Republic of Ireland and the Companies Act 2006.

 
Page 2